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SYSTEMATIC REVIEW
Septoplasty for nasal obstruction due to a deviated nasal 
septum in adults: a systematic review*
Background: The status of current evidence for the effectiveness of septoplasty is unclear. This systematic review evaluates the ef-
fectiveness of a) septoplasty (with or without concurrent turbinate surgery) versus non-surgical management, and b) septoplasty 
with concurrent turbinate surgery versus septoplasty alone, for nasal obstruction due to a deviated nasal septum in adults.
Methodology: Eligible for inclusion were randomised controlled trials and non-randomised designs comparing treatment stra-
tegies. Risk of bias was assessed using Cochrane’s tool. Standardised mean differences and risk differences with 95% confidence 
intervals were calculated. Substantial heterogeneity between included studies did not allow meta-analyses.
Results: No studies were found comparing septoplasty (with or without concurrent turbinate surgery) to non-surgical manage-
ment, but 11 articles were included to compare septoplasty with concurrent turbinate surgery to septoplasty alone. Five studies 
described both subjective and objective outcomes; six studies reported one or the other. Risk of bias was overall high. Although 
outcomes generally improved after treatment, eight out of nine studies on subjective measures and five out of seven studies on 
objective measures found no additional benefit of turbinate surgery.
Conclusions: Despite the routine application of septoplasty in clinical practice, the current body of evidence does not support 
firm conclusions on its effectiveness.
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Introduction
Septoplasty, i.e., surgical correction of the deviated nasal sep-
tum, is the most common ENT-operation in adults (1). However, 
indications seem practice-based rather than evidence-based 
and internationally accepted guidelines are lacking (2). Annual 
septoplasty rates differ accordingly between countries. The 
number of septoplasties per 10,000 inhabitants was 3.9 in Eng-
land, 6.6 in the Netherlands, and 12.2 in Germany in 2014 (3-5). In 
the United States, the annual septoplasty rate was 8.7 per 10,000 
inhabitants in 2006 (6).
The main indication for septoplasty is nasal obstruction, 
commonly defined as an unpleasant sensation of insufficient 
airflow through the nose (7). Nasal obstruction is associated with 
mucosal as well as anatomical conditions. Underlying patho-
genesis may be multifactorial. The most frequent anatomical 
cause is a deviated nasal septum, which can be accompanied 
by hypertrophy of the turbinate contralateral to the deviation 
(8). Septoplasty (with or without concurrent turbinate surgery) is 
performed to widen nasal passages and thereby improve nasal 
airflow (9).
Nonetheless, the effectiveness of septoplasty and additional 
benefits of turbinate surgery are questioned. According to the 
literature, nasal septal deviation may have a prevalence of up 
to 80%, whereas only a minority suffers from nasal obstruction. 
Whether straightening the deviated septum provides any bene-
fit to those patients, remains a topic of debate in ENT-practice 
(10). The American Academy of Otolaryngology – Head and Neck 
Surgery initiated a consensus panel on septal surgery, which 
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failed to reach agreement in over one third of the 33 controver-
sial clinical dilemmas discussed (11). Both in the United Kingdom 
and in the Netherlands, professional associations of ENT-surge-
ons recognised a need for evidence to advance the debate on 
indications for and benefits of septoplasty (12, 13).
The lack of clinical consensus is, however, accompanied by scar-
city of scientific literature. Randomised controlled trials seem 
underrepresented and the status of (other) existing evidence is 
unclear. Remarkably, this does not appear to hamper the routine 
application of septoplasty in daily practice (2). Therefore we 
decided to perform a systematic review of available evidence, 
including non-randomised designs. The aims of this systematic 
review are: to evaluate the effectiveness of a) septoplasty (with 
or without concurrent turbinate surgery) versus non-surgical 
management, and b) septoplasty with concurrent turbinate 
surgery versus septoplasty alone, for nasal obstruction due to 
a deviated nasal septum in adults. By discussing the findings, 
strengths, and weaknesses of available studies, we intend to 
assess the status of current evidence for the effectiveness of 
septoplasty.
Materials and methods
Protocol registration
The review protocol can be accessed at the website of PROSPE-
RO, the International Prospective Register of Systematic Reviews 
(https://www.crd.york.ac.uk/PROSPERO/). The protocol was 
registered under the number CRD42017060632 on March 31, 
2017.
Eligibility criteria
Participants
Studies in adults with nasal obstruction due to a deviated nasal 
septum were considered eligible for inclusion in this review. 
In clinical practice, nasal obstruction due to a deviated nasal 
septum is primarily diagnosed by an internal exam of the nose, 
consisting of anterior rhinoscopy and nasal endoscopy. The in-
ternal exam is performed by the ENT-surgeon to assess whether 
the deviation causes a mechanical nasal airway obstruction, 
leading to impaired nasal breathing (14). For this review, the study 
authors’ definition of nasal obstruction due to a deviated nasal 
septum was adopted. In included studies, nasal obstruction had 
to be the primary indication for performing septoplasty. Studies 
in which patients were selected for septoplasty because of other 
complaints (e.g., impairment of normal sinus drainage, sleep 
disorders, headaches) were excluded. Studies in the following 
patient categories were also excluded: patients with a history 
of nasal septal surgery; patients with nasal septal perforation; 
patients with untreated allergic rhinitis or allergic rhinitis 
unresponsive to medical treatment; and cleft lip and/or palate 
patients.
Intervention and comparison
Included studies had to compare septoplasty (with or without 
concurrent turbinate surgery) to non-surgical management, or 
septoplasty with turbinate surgery to septoplasty alone. Non-
surgical management could consist of watchful waiting and 
medical treatment, such as local or systemic steroids and antihis-
tamines. Studies in which septoplasty was combined with other 
procedures than turbinate surgery (e.g., rhinoplasty, spreader 
grafts, butterfly grafts, FESS, adenoidectomy) were excluded. 
Outcomes
Follow-up needed to be at least three months to prevent direct 
postoperative effects like mucosal swelling from distorting out-
come assessment. Desirable time points of outcome assessment 
were three months, six months, 12 months, and 24 months. Both 
subjective (e.g., health-related quality of life) as well as objective 
(e.g., nasal patency) outcome measures were taken into account. 
Health-related quality of life may be measured using patient-
based questionnaires such as the Glasgow Benefit Inventory 
(GBI), Nasal Obstruction Symptom Evaluation (NOSE) Scale, and 
the Sino-Nasal Outcome Test (SNOT) (15-17). Visual Analog Scales 
(VAS) or Likert scales can be applied to grade symptom severity 
(18, 19). For the objective assessment of nasal patency, several 
outcome measures are available, e.g., Peak Nasal Inspiratory 
Flow (PNIF), Acoustic Rhinometry (AR), or Active Anterior Rhino-
manometry (AAR), which may be performed with a Four-Phase 
Rhinomanometer (4PR) (14, 20, 21).  
Other eligibility criteria
The preferred study design was a randomised controlled trial 
comparing either septoplasty to non-surgical management, or 
septoplasty with concurrent turbinate surgery to septoplasty 
alone. We were, however, apprehensive of not finding any RCTs. 
As it was our aim to assess the status of currently available 
evidence, we also considered the following study designs for 
inclusion in this review: quasi-randomised trials; cohort studies 
comparing interventions; non-randomised controlled trials; case 
control studies; and controlled before-and-after studies. We 
excluded opinion articles, animal studies, (systematic) reviews, 
case reports, conference abstracts, and studies on other inter-
ventions (e.g., nasal packing, various analgesia, postoperative 
care).
Information sources and search strategy
We systematically searched PubMed, the Cochrane Library (both 
from inception) and Ovid EMBASE (from 1974) up to October 10, 
2017 for studies on septoplasty for nasal obstruction in adults 
with a deviated nasal septum. Terms relating to the patients, in-
tervention, and outcomes were included in the search strategy, 
which combined synonyms for nasal obstruction, nasal septal 
deviation, septoplasty, turbinate surgery, and various subjective 
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clusion in this review, we paid special attention to the execution 
of the studies and the risk of selection bias, confounding, and 
reporting bias including selective reporting of outcomes. For all 
included studies, it was evaluated whether a study protocol was 
available and if so, whether the study’s pre-specified outcomes 
had been reported. Moreover, we intended to quantify publicati-
on bias with a funnel plot of the intervention effect estimate on 
the horizontal axis and the measure of study size on the vertical 
axis, but this proved to be impossible due to the great variety in 
outcome measures applied across a small number of included 
studies. Results of risk of bias assessment were graphically sum-
marised using Review Manager 5 (RevMan5) software (version 
5.3, Cochrane Collaboration, London, England).
Summary measures and synthesis of results
We planned to calculate standardised mean differences (for 
continuous outcomes) and risk differences (for dichotomous 
outcomes) with their corresponding 95% confidence intervals 
using RevMan 5 software. Ultimately, the studies included in 
our systematic review were too heterogeneous to perform 
meta-analyses, see also Table 1. For this reason, effect estimates 
reported in the individual studies were presented.
Results 
Study selection
Our systematic search of PubMed, the Cochrane Library, and 
Ovid EMBASE yielded a total of 16,232 records, which was 
reduced to 10,919 results after removing duplicates. By scanning 
articles’ reference lists we found one additional study, which was 
as well as objective outcome measures. Both keywords (MeSH 
and Emtree) and free-text terms in title and abstract were inclu-
ded in the search query. Intervention terms were combined with 
nose-related synonyms to minimise noise from cardiovascular 
studies on surgery of the interventricular septum. No language 
or date restrictions were applied. In addition to the electronic 
search, articles’ reference lists were scanned for any applicable 
studies that had not yet been identified.
Study selection
The results of the search strategy were merged and duplicates 
were removed using EndNote reference management soft-
ware (version X7, Thomas Reuters, New York City, NY, USA). 
Two review authors (MvE, NvH) individually screened titles and 
abstracts to identify relevant reports based on the inclusion and 
exclusion criteria outlined above. Full texts of these potentially 
relevant studies were retrieved by a librarian (AT) and indepen-
dently assessed for eligibility by two reviewers (MvE and NvH). 
Any disagreements were resolved by discussion with a third 
reviewer (MR).
Data extraction
Data extraction was conducted by one reviewer (MvE) using a 
pre-defined form. Unclear issues were discussed with two other 
reviewers (NvH, MR) and resolved by consensus. The following 
data were extracted from included studies: study design; des-
cription of participants (eligibility criteria, total number, mean 
age, gender, country of origin, type and severity of nasal septal 
deviation, prior treatment); total number of intervention groups; 
intervention details (type of surgery or specifics of non-surgical 
treatment); number of participants allocated to each interven-
tion group; total duration of follow-up; time points of outcome 
assessment during follow-up; primary and secondary outcomes 
collected and reported; missing data for each intervention 
group; summary data for each intervention group; and the 
authors' conclusions.
Risk of bias assessment
Risk of bias in included studies was independently assessed by 
two review authors (MvE, NvH). Any differences in opinion were 
resolved by discussion with a third review author (MR). Included 
studies were evaluated using Cochrane’s risk of bias tool, which 
comprises a critical assessment of random sequence generation, 
allocation concealment, blinding of participants and personnel, 
blinding of outcome assessment, incomplete outcome data, 
selective reporting, and other sources of bias (22). Each domain 
in every individual study was assigned either a high, low, or 
unclear risk of bias, based on the study report and, if applicable, 
correspondence with study authors. Blinding of outcome assess-
ment was scored separately for subjective and objective outco-
mes. Since non-randomised studies were also considered for in-
Figure 1. Flow diagram of study selection.
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potentially applicable even though it had not been indexed in 
either one of the three databases searched. Based on title and 
abstract, 10,885 articles needed to be excluded due to incom-
patibility with our eligibility criteria. Full-texts of the remaining 
35 studies were screened and another 24 articles were excluded 
for the following reasons: in 14 studies, the control group either 
lacked or was unsuitable to compare treatments; five studies did 
not comply with our eligibility criteria concerning patients, in-
terventions, or follow-up; two articles were (systematic) reviews; 
two articles were conference abstracts; and one publication 
was solely based on expert opinion. A total of 11 articles could 
be included in this systematic review. A flow diagram of study 
selection is shown in Figure 1, derived from The Preferred Repor-
ting Items for Systematic Reviews and Meta-Analyses (PRISMA) 
Group (23).
Study characteristics
The first aim of this review was to assess the effectiveness of 
septoplasty (with or without concurrent turbinate surgery) 
versus non-surgical management for nasal obstruction due to 
Table 1. Schematic overview of clinical and methodological differences between included studies.
*Likert scale ranged 5 points in Akduman et al. and 11 points in Stewart et al. † Long-term follow-up of Grymer et al. ‡ The study authors included 35 
patients who underwent septoplasty and additional valve surgery; effect estimates of these patients were not included in this systematic review. AAR: 
Active Anterior Rhinomanometry. AR: Acoustic Rhinometry. CBA: Controlled Before-and-After study. CT: Computed Tomography measurements of 
turbinate thickness. GBI: Glasgow Benefit Inventory. NOSE: Nasal Obstruction Symptom Evaluation scale. PRQ: Patient-Reported Questionnaire con-
cerning nasal symptoms or treatment satisfaction; not otherwise specified by study authors. RCT: Randomised Controlled Trial. SNOT-20: Sino-Nasal 
Outcome Test-20. ITH: Inspiratory air Temperature and absolute Humidity. VAS: Visual Analogue Scale. 
First author, 
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design)
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RCT
Devseren, 
2010 (30)
67 X X X X 6
Grymer, 
1993 (31)
80 ? ? X X X 3
Illum, 
1997† (32)
80 ? ? X X X 60
Lindemann, 
2008 (33)
12 X X X 6
Nasseem, 
2009 (34)
86 ? ? X X X 9
CBA
Akduman, 
2013 (24)
134 ‡ ? ? X X X X X 6
Balcerzak, 
2014 (25)
30 ? ? X X X X 6
Dinesh 
Kumar, 
2015 (29)
60 X X X 6
Stewart, 
2004 (26)
59 X X X X 6
Uppal, 
2005 (27)
75 ? ? X X X X 44
Ye, 
2006 (28)
83 ? ? X X X 6
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Table 2. Characteristics of included studies.
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*The study authors have calculated mean age, age range, and number of males based 
on 42 patients, as 25 patients were lost to follow-up and excluded from further analyses. 
† Long-term follow-up of Grymer et al. ‡ The study authors included 35 patients who 
underwent septoplasty and additional valve surgery; effect estimates of these patients 
were not included in this systematic review. Mean age, age range, and number of 
males were presented based on the total sample of 134 patients. AAR: Active Anterior 
Rhinomanometry. AR: Acoustic Rhinometry. CBA: Controlled Before-and-After study. 
GBI: Glasgow Benefit Inventory. NOSE: Nasal Obstruction Symptom Evaluation scale. NR: 
Not Reported. RCT: Randomised Controlled Trial. SA: Septoplasty Alone. SNOT-20: Sino-
Nasal Outcome Test-20. ST: Septoplasty with concurrent Turbinate surgery. VAS: Visual 
Analogue Scale.
a deviated nasal septum in adults. We were not able to include 
any studies with respect to this comparison. 
The second aim was to compare septoplasty with concurrent 
turbinate surgery versus septoplasty alone for nasal obstruction 
due to a deviated nasal septum in adults. For this comparison, 
five randomised controlled trials and six controlled before-and-
after studies (in which measurements were performed before 
and after treatment, both in patients undergoing septoplasty 
with concurrent turbinate surgery and in patients undergoing 
septoplasty alone) could be included. The number of included 
participants per study varied between 12 and 134 patients. The 
preoperative diagnostic assessment consisted of anterior rhino-
scopy and nasal endoscopy in most cases. The type of turbinate 
surgery was often described as (anterior) turbinoplasty or partial 
turbinectomy. In the majority of studies, turbinate surgery was 
unilateral. Table 2 provides an overview of included studies 
and details on their methods, participants, interventions, and 
outcomes.
Risk of bias assessment
Results of risk of bias assessment are graphically summarised in 
Figures 2 and 3. In Figure 2, judgments about each risk of bias 
item are presented as percentages across all included studies, 
whereas Figure 3 shows scores on each risk of bias item for every 
included study separately.
Sequence generation and allocation concealment
In five out of 11 included studies, the indication to have septo-
plasty performed with or without turbinate surgery was based 
on clinical judgment or patient preferences (24-28). In one study, 
correspondence with study authors learned that patients were 
alternately divided between two groups (29). The remaining five 
studies all mentioned a random component in the sequence 
generation process. None of these studies, however, reported an 
adequate method of allocation concealment (30-34). 
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Blinding
Only two publications described efforts to prevent performance 
bias due to knowledge of the allocated interventions. Both 
in Balcerzak et al. and Stewart et al., ENT-surgeons were not 
involved in collecting follow-up data (25, 26). Moreover, Stewart et 
al. blinded physicians to patients’ pre- and postoperative scores 
on study outcomes (26). 
The risk of detection bias was assessed separately for subjective 
and objective outcomes. In all included studies, patients were 
aware of the type of surgery performed. Taking the patients’ 
perspective into account, we estimated that the difference in 
perceived desirability between two types of surgical treatment 
would be less pronounced than between septoplasty and non-
surgical management. For this reason, most subjective outcome 
measurements were considered unlikely to be influenced by 
lack of blinding. The risk of detection bias was found to be high 
only in Grymer et al. and Illum et al., since subjective outcomes 
of these studies mainly addressed satisfaction with the treat-
ment received (31, 32). For objective outcomes, the risk of detecti-
on bias was judged to be low irrespective of the lack of blinding. 
Incomplete outcome data and selective reporting
Four studies reported that all outcome data were complete (27, 
28, 33, 34). In two studies, no information on missing outcome data 
was provided (25, 29). Four other studies presented proportions of 
missing outcomes, but reasons for loss to follow-up were rarely 
stated and adequate methods for handling incomplete outcome 
data were never described (26, 30-32). Some studies appeared to 
have adopted a per protocol approach by simply excluding 
dropouts (24, 30, 31).
A study protocol could not be obtained for any of the included 
studies. Moreover, none of the randomised controlled trials 
were listed on ClinicalTrials.gov or in the ISRCTN (International 
Standard Randomised Controlled Trial Number) Registry. Con-
sequently, it was impossible to verify whether all of the studies’ 
pre-specified outcomes had been published. Obvious evidence 
of selective outcome reporting was identified only in Stewart et 
al., where one of the outcome measures listed in the Methods 
section (i.e., an 11-point Likert scale) was entirely omitted from 
the Results (26). Additionally, risk of reporting bias was high in 
seven other studies, whose summary measures could not be 
calculated due to incomplete reporting of outcomes (24, 27, 29-33).
Other potential sources of bias
Systematic differences in baseline characteristics between the 
two groups were likely to have occurred especially in studies 
allocating treatments based on clinical judgment or patient 
preferences (24-28).
Furthermore, specific issues that raised concern about the possi-
bility of bias were identified in two of the controlled before-and-
after studies and three of the included RCTs. In Akduman et al., 
patients were allocated to septoplasty alone, septoplasty with 
concurrent turbinate surgery, or septoplasty with additional 
valve surgery (24). Given this third treatment option, the selection 
of patients enrolled in our two groups of interest may have been 
different, had only two options been present. Dinesh Kumar et 
al. presented inconsistent tables, which showed different num-
bers for the same outcomes (29). In Devseren et al. and Grymer 
et al., respectively two and six patients with postoperative com-
plications were excluded from the analyses (30, 31). Nasseem et al. 
performed additional turbinate surgery in patients allocated to 
septoplasty alone in case of persistent complaints (34). 
 
Study results
A summary of findings from included studies is provided in 
Table 3. In case of repeated measurements, we planned to 
Figure 2. Risk of bias graph: review authors’ judgment about each risk of bias item presented as percentages across all included studies.
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present outcomes at 12 months. In none of the included studies, 
however, data were collected at one year of follow-up. Median 
follow-up was six months; data at this time point were presen-
ted whenever possible (24-26, 28-30, 33, 34). In the remaining three 
studies, no repeated measurements were conducted. Therefore, 
we presented outcomes at the time point selected by study 
authors, which ranged between three and 60 months (27, 31, 32).
Subjective outcome measures
Subjective outcomes were reported in nine out of 11 included 
studies (24-27, 29-32, 34). Six different subjective outcome measures 
could be distinguished, some of which were applied in only one 
study (i.e., SNOT-20, VAS) and others in two to three studies (i.e., 
GBI, Likert scale, NOSE); four studies assessed nasal symptoms 
Figure 3. Risk of bias summary: review authors’ judgment about each risk 
of bias item for every included study.
or treatment satisfaction using a patient-reported questionnaire 
(PRQ) which was not otherwise specified by study authors. Eight 
out of nine studies reported subjective benefit after treatment, 
irrespective of whether septoplasty had been performed with 
or without concurrent turbinate surgery. Only Dinesh Kumar et 
al. reported that septoplasty with concurrent turbinate surgery 
resulted in significantly greater improvement in symptoms than 
septoplasty alone, but the basis for this conclusion was unclear 
due to inconsistent reporting of results within this study (29). 
Objective outcome measures
Objective outcomes were reported in seven studies. Four types 
of objective outcome measures were described, i.e., active 
anterior rhinomanometry, acoustic rhinometry, CT measure-
ments of turbinate thickness, and measurements of inspiratory 
air temperature and absolute humidity. Each objective outcome 
was used in one study apart from AR, which was applied in 
four studies. Three reports indicated that AAR or AR had been 
performed after decongestion of nasal mucosa; Devseren et al. 
and Ye et al. did not specify whether this was the case (28, 30). Most 
studies reported significant improvement in objective outcomes 
after treatment (28, 30, 31, 33, 34). Five out of seven studies found no 
additional benefit of concurrent turbinate surgery (25, 28, 30, 32, 33).
Complications
Only three studies reported on complications (30, 31, 34). The most 
frequent complications were development of nasal septal per-
foration and nasal adhesions or synechiae, with a reported total 
of seven and six affected patients out of 233, respectively. Other 
complications were nasal hematoma and secondary hemorr-
hage, each of which occurred in one out of 233 patients (34). In all 
three studies, complications were more frequent after septo-
plasty with concurrent turbinate surgery than after septoplasty 
alone.
Discussion
Summary of evidence
This systematic review includes five randomised controlled trials 
and six controlled before-and-after studies comparing the ef-
fectiveness of septoplasty with concurrent turbinate surgery to 
septoplasty alone for nasal obstruction due to a deviated nasal 
septum in adults. Included studies demonstrated substantial 
heterogeneity in study population, outcomes measured, and 
time points of outcome assessment. Risk of bias was conside-
red high in most reports. Therefore we decided not to perform 
meta-analyses, but instead present effect estimates of individual 
studies. Subjective and objective outcomes generally appeared 
to have improved after treatment. However, the additional be-
nefit of turbinate surgery was not evident. Moreover, subjective 
benefit was not always accompanied by objective improvement, 
and vice versa. Complications appeared to be rare and were re-
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ported in only three studies. Most complications occurred after 
septoplasty with concurrent turbinate surgery.
Strengths and limitations
The major strength of our systematic review is that we are the 
first to provide an extensive evaluation of current evidence for 
the effectiveness of septoplasty (with or without concurrent 
turbinate surgery) as well as for the effectiveness of septoplasty 
with concurrent turbinate surgery compared to septoplasty 
alone, both in terms of subjective and objective outcome 
measures. Considering its annual performance rate combined 
with the existing lack of management consensus, evidence for 
the effectiveness of septoplasty is of high relevance to many 
healthcare providers, patients, and policy makers. This syste-
matic review has been performed with strict adherence to the 
registered review protocol and following PRISMA guidelines (23). 
However, several limitations should be addressed as well. First, a 
non-surgical control group was lacking in all eligible studies. Sin-
ce improvement in complaints could also be induced by other 
factors such as natural history, beneficial effects of surgery may 
be overestimated. Some study authors considered septoplasty 
the only possible treatment for a deviated nasal septum (24, 26). 
Yet the primary aim of septoplasty is reducing symptoms of 
nasal obstruction, rather than merely straightening the septum. 
For this purpose, non-surgical management is an equally suited 
alternative under conditions of clinical equipoise (35). 
Second, follow-up of most included studies was relatively 
short. This may provide a distorted view on the effectiveness 
of septoplasty, as long-term results tend to be less favourable 
than short-term outcomes. Illum et al. found that only 39 to 50 
percent of patients remained satisfied 5 years after treatment (32). 
An uncontrolled study by Jessen et al. showed that the propor-
tion of patients relieved of nasal obstruction dropped from 51 
percent at 9 months of follow-up to 26 percent after 9 years 
(36). To assess durability of symptom improvement, studies with 
longer follow-up are needed.
Third, we used Cochrane’s risk of bias tool instead of the 
*Outcome decreases with improvement after treatment. †Outcome increases with improvement after treatment. 
‡Minimal cross-sectional area (MCA) in cm2. §End-inspiratory increase in air temperature (in °C) and absolute 
humidity (in g/m3). ¶CT measurements of turbinate thickness in mm; outcomes available only at 9 months of 
follow-up. || Nasal resistance in Pa/mL/s; means and standard deviations provided by study authors were change 
scores. AAR: Active Anterior Rhinomanometry. AR: Acoustic Rhinometry. CBA: Controlled Before-and-After study. 
CI: Confidence Interval CT: Computed Tomography measurements of turbinate thickness. GBI: Glasgow Benefit 
Inventory. ITH: Inspiratory air Temperature and absolute Humidity. NOSE: Nasal Obstruction Symptom Evaluation 
scale. NR: Not Reported. PRQ: Patient-Reported Questionnaire concerning nasal symptoms or treatment satis-
faction; not otherwise specified by study authors. RCT: Randomised Controlled Trial. SA: Septoplasty Alone. SD: 
Standard Deviation. SMD: Standardised Mean Difference. SNOT-20: Sino-Nasal Outcome Test-20. ST: Septoplasty 
with concurrent Turbinate surgery. VAS: Visual Analogue Scale.
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